Your browser doesn't support javascript.
loading
ARGX-117, a therapeutic complement inhibiting antibody targeting C2.
Van de Walle, Inge; Silence, Karen; Budding, Kevin; Van de Ven, Liesbeth; Dijkxhoorn, Kim; de Zeeuw, Elisabeth; Yildiz, Cafer; Gabriels, Sofie; Percier, Jean-Michel; Wildemann, Johanna; Meeldijk, Jan; Simons, Peter J; Boon, Louis; Cox, Linda; Holgate, Rob; Urbanus, Rolf; Otten, Henny G; Leusen, Jeanette H W; Blanchetot, Christophe; de Haard, Hans; Hack, C Erik; Boross, Peter.
Afiliação
  • Van de Walle I; argenx BVBA, Zwijnaarde, Belgium. Electronic address: ivandewalle@argenx.com.
  • Silence K; argenx BVBA, Zwijnaarde, Belgium.
  • Budding K; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Van de Ven L; argenx BVBA, Zwijnaarde, Belgium.
  • Dijkxhoorn K; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • de Zeeuw E; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Yildiz C; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Gabriels S; argenx BVBA, Zwijnaarde, Belgium.
  • Percier JM; argenx BVBA, Zwijnaarde, Belgium.
  • Wildemann J; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Meeldijk J; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Simons PJ; Bioceros BV, Utrecht, The Netherlands.
  • Boon L; Bioceros BV, Utrecht, The Netherlands.
  • Cox L; Bioceros BV, Utrecht, The Netherlands.
  • Holgate R; Antitope Ltd, Cambridge, United Kingdom.
  • Urbanus R; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands; Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Otten HG; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Leusen JHW; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Blanchetot C; argenx BVBA, Zwijnaarde, Belgium.
  • de Haard H; argenx BVBA, Zwijnaarde, Belgium.
  • Hack CE; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands; Prothix BV, Leiden, The Netherlands.
  • Boross P; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands; Prothix BV, Leiden, The Netherlands. Electronic address: peterboross@gmail.com.
J Allergy Clin Immunol ; 147(4): 1420-1429.e7, 2021 04.
Article em En | MEDLINE | ID: mdl-32926878
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complemento C2 / Inativadores do Complemento / Anticorpos Monoclonais Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complemento C2 / Inativadores do Complemento / Anticorpos Monoclonais Idioma: En Ano de publicação: 2021 Tipo de documento: Article